Clinical Trial: A Study to Determine the Safety and Effectiveness of the Investigational Cellular Therapy GCAR1 in a Patient With Alveolar Soft Part Sarcoma

U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07104682) titled 'A Study to Determine the Safety and Effectiveness of the Investigational Cellular Therapy GCAR1 in a Patient With Alveolar Soft Part Sarcoma' on July 29.

Brief Summary: A single patient study to determine whether GCAR1 is safe and effective for refractory, progressive metastatic alveolar soft part sarcoma (ASPS).

Study Start Date: Aug. 08

Study Type: INTERVENTIONAL

Condition: Alveolar Soft Part Sarcoma (ASPS) Sarcoma

Intervention: BIOLOGICAL: GCAR1

GCAR1 is a patient-specific cell therapy product containing a mixture of autologous lymphocytes transduced with a lentiviral vector encoding a chimeric antigen receptor (CAR) target...